As a pioneer transcription factor, GATA2 has capability of binding to the DNA regions of closed chromatin, initiating hierarchical recruitment and occupancy of other regulatory proteins and forming a complicated transcriptional protein complex, which provide a promising therapeutic strategy by disrupting the protein–protein interactions (PPIs) in PCa treatment [15, 23]. Here, GATA2 is linked to posterior cortical atrophy.